McGlone Suttner Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-293
Closed -$6.57K 219
2023
Q4
$6.57K Buy
+293
New +$6.05K ﹤0.01% 551

Other funds holding AVNS

McGlone Suttner Wealth Management's AVNS Position: Q1 2024 in Review

McGlone Suttner Wealth Management sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 293 shares — an estimated $6.57K sold.

McGlone Suttner Wealth Management first reported a position in AVNS in Q4 2023 and held it in 1 quarter. The position peaked at $6.57K in Q4 2023. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

  • McGlone Suttner Wealth Management reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
  • McGlone Suttner Wealth Management sold 293 Avanos Medical shares in Q1 2024, an estimated $6.57K.
  • McGlone Suttner Wealth Management first reported a position in Avanos Medical in Q4 2023 and held it in 1 quarter.
  • McGlone Suttner Wealth Management's Avanos Medical position peaked at $6.57K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on McGlone Suttner Wealth Management's 13F filing for Q1 2024, filed 18 Apr 2024.